BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23124902)

  • 1. Multivalent proteoglycan modulation of FGF mitogenic responses in perivascular cells.
    Cattaruzza S; Ozerdem U; Denzel M; Ranscht B; Bulian P; Cavallaro U; Zanocco D; Colombatti A; Stallcup WB; Perris R
    Angiogenesis; 2013 Apr; 16(2):309-27. PubMed ID: 23124902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan.
    Ozerdem U; Stallcup WB
    Angiogenesis; 2004; 7(3):269-76. PubMed ID: 15609081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chondroitin sulfate proteoglycan 4 (NG2/CSPG4) on soft-tissue sarcoma growth depend on tumor developmental stage.
    Hsu SC; Nadesan P; Puviindran V; Stallcup WB; Kirsch DG; Alman BA
    J Biol Chem; 2018 Feb; 293(7):2466-2475. PubMed ID: 29196603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor.
    Brand C; Schliemann C; Ring J; Kessler T; Bäumer S; Angenendt L; Mantke V; Ross R; Hintelmann H; Spieker T; Wardelmann E; Mesters RM; Berdel WE; Schwöppe C
    Oncotarget; 2016 Feb; 7(6):6774-89. PubMed ID: 26735180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NG2 Proteoglycan in Pericyte Biology.
    Stallcup WB
    Adv Exp Med Biol; 2018; 1109():5-19. PubMed ID: 30523586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor receptor 1 is principally responsible for fibroblast growth factor 2-induced catabolic activities in human articular chondrocytes.
    Yan D; Chen D; Cool SM; van Wijnen AJ; Mikecz K; Murphy G; Im HJ
    Arthritis Res Ther; 2011 Aug; 13(4):R130. PubMed ID: 21835001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NG2/CSPG4-collagen type VI interplays putatively involved in the microenvironmental control of tumour engraftment and local expansion.
    Cattaruzza S; Nicolosi PA; Braghetta P; Pazzaglia L; Benassi MS; Picci P; Lacrima K; Zanocco D; Rizzo E; Stallcup WB; Colombatti A; Perris R
    J Mol Cell Biol; 2013 Jun; 5(3):176-93. PubMed ID: 23559515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NG2 proteoglycan promotes tumor vascularization via integrin-dependent effects on pericyte function.
    You WK; Yotsumoto F; Sakimura K; Adams RH; Stallcup WB
    Angiogenesis; 2014 Jan; 17(1):61-76. PubMed ID: 23925489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute brain injuries trigger microglia as an additional source of the proteoglycan NG2.
    Huang W; Bai X; Meyer E; Scheller A
    Acta Neuropathol Commun; 2020 Aug; 8(1):146. PubMed ID: 32843103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein Kinase CK2 Regulates Nerve/Glial Antigen (NG)2-Mediated Angiogenic Activity of Human Pericytes.
    Schmitt BM; Boewe AS; Becker V; Nalbach L; Gu Y; Götz C; Menger MD; Laschke MW; Ampofo E
    Cells; 2020 Jun; 9(6):. PubMed ID: 32630438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diversified expression of NG2/CSPG4 isoforms in glioblastoma and human foetal brain identifies pericyte subsets.
    Girolamo F; Dallatomasina A; Rizzi M; Errede M; Wälchli T; Mucignat MT; Frei K; Roncali L; Perris R; Virgintino D
    PLoS One; 2013; 8(12):e84883. PubMed ID: 24386429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced inflammation accompanies diminished myelin damage and repair in the NG2 null mouse spinal cord.
    Kucharova K; Chang Y; Boor A; Yong VW; Stallcup WB
    J Neuroinflammation; 2011 Nov; 8():158. PubMed ID: 22078261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal Tumors Can Derive from Ng2/Cspg4-Expressing Pericytes with β-Catenin Modulating the Neoplastic Phenotype.
    Sato S; Tang YJ; Wei Q; Hirata M; Weng A; Han I; Okawa A; Takeda S; Whetstone H; Nadesan P; Kirsch DG; Wunder JS; Alman BA
    Cell Rep; 2016 Jul; 16(4):917-927. PubMed ID: 27425618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acidic fibroblast growth factor (FGF-1) and FGF receptor 1 signaling in human Y79 retinoblastoma.
    Siffroi-Fernandez S; Cinaroglu A; Fuhrmann-Panfalone V; Normand G; Bugra K; Sahel J; Hicks D
    Arch Ophthalmol; 2005 Mar; 123(3):368-76. PubMed ID: 15767480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chondroitin sulfate and heparan sulfate-containing proteoglycans are both partners and targets of basic fibroblast growth factor-mediated proliferation in human metastatic melanoma cell lines.
    Nikitovic D; Assouti M; Sifaki M; Katonis P; Krasagakis K; Karamanos NK; Tzanakakis GN
    Int J Biochem Cell Biol; 2008; 40(1):72-83. PubMed ID: 17706452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of fibroblast growth factors and their receptors in prostate cancer.
    Kwabi-Addo B; Ozen M; Ittmann M
    Endocr Relat Cancer; 2004 Dec; 11(4):709-24. PubMed ID: 15613447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel type I fibroblast growth factor receptor activates mitogenic signaling in the absence of detectable tyrosine phosphorylation of FRS2.
    Lopez ME; Korc M
    J Biol Chem; 2000 May; 275(21):15933-9. PubMed ID: 10748122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Participation of the NG2 proteoglycan in rat aortic smooth muscle cell responses to platelet-derived growth factor.
    Grako KA; Stallcup WB
    Exp Cell Res; 1995 Nov; 221(1):231-40. PubMed ID: 7589250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligodendrocyte precursor cells modulate the neuronal network by activity-dependent ectodomain cleavage of glial NG2.
    Sakry D; Neitz A; Singh J; Frischknecht R; Marongiu D; Binamé F; Perera SS; Endres K; Lutz B; Radyushkin K; Trotter J; Mittmann T
    PLoS Biol; 2014 Nov; 12(11):e1001993. PubMed ID: 25387269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice.
    Girolamo F; Errede M; Longo G; Annese T; Alias C; Ferrara G; Morando S; Trojano M; Kerlero de Rosbo N; Uccelli A; Virgintino D
    PLoS One; 2019; 14(3):e0213508. PubMed ID: 30870435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.